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Abstract: Evidence from cell studies indicates that persistent organic pollutants (POP) can 
induce insulin resistance, an essential component of the metabolic syndrome (MetS). We 
hypothesized  that  residential  proximity  to  environmental  sources  of  POP  would  be 
associated with the MetS in the population. The present study examined the association 
between residency in a zip code containing or abutting environmental sources of POP and  
MetS-related hospitalization rates. Hospitalization data were obtained from the New York 
Statewide Planning and Research Cooperative System. Relative risks (RR) were calculated 
as hospitalization rate ratios. Adjusted RR and their 95% confidence intervals (CI) were 
estimated by multivariable Poisson regression. A higher proportion of African Americans 
resided  in  POP  zip  codes  compared  to  Caucasians  (25.9%  and  24.3%,  respectively,  
p < 0.01). Residence in POP zip codes was associated with a statistically significant 39.2% 
increase in MetS-related hospitalization rates, adjusted for race, gender, and age (adjusted 
RR  =  1.392,  95%  CI:  1.032–1.879,  p  =  0.030).  Increase  in  age  was  independently 
associated  with  higher  MetS-related  hospitalization  rates  (p  for  trend  <  0.001).  Our 
findings contribute to the body of evidence supporting the hypothesis of POP constituting 
an environmental risk factor for the MetS. Further studies investigating exposure to POP 
and insulin resistance are warranted. 
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1. Introduction 
The metabolic syndrome (MetS) constitutes a growing problem of a serious public health and health 
care concern not only because of its increase in the population in recent years, but also because it’s a 
major risk factor for cardiovascular diseases, which is the leading cause of death in the United States 
and  worldwide  [1,2].  Age-adjusted  prevalence  of  the  MetS  in  the  U.S.  adult  population  has  
grown  from  below  24%  in  1988–1994  to  34%  in  2003–2006  [3,4].  The  MetS  is  a  clustering  of  
metabolism-related disorders and conditions that may share common pathophysiological mechanisms: 
including  glucose  intolerance/insulin  resistance,  abdominal  obesity,  dyslipidemia,  and  high  blood 
pressure—hypertension  (HTN)  [5,6].  Insulin  resistance  and  obesity  play  the  central  role  in  the 
pathophysiology of the MetS. A formalized clinical definition of the MetS includes having any three of 
the following five criteria: waist circumference over 40 inches (men) or over 35 inches (women); 
fasting  glucose  100  or  higher  mg/dL  or  currently  on  medication  for  an  elevated  glucose  level; 
triglycerides 150 or higher mg/dL or currently on medication for hypertriglyceridemia; high-density 
lipoprotein (HDL) cholesterol below 40 mg/dL (men) or below 50 mg/dL (women) or currently on 
medication for low HDL cholesterol level; systolic blood pressure over 130 mm Hg or diastolic blood 
pressure over 85 mm Hg or currently on medication for HTN [7].  
The MetS increases risk of myocardial infarction (heart attack) and stroke; it is also associated with 
an increased cardiovascular disease mortality and all-cause mortality [8,9]. 
Persistent organic pollutants (POP) are a group of organic compounds that are highly resistant to 
chemical, photolytic, and biological degradation. These lipophilic compounds are persistent  in the 
environment  and  human  body.  POP  include  polychlorinated  biphenyls  (PCB),  polychlorinated 
dibenzo-p-dioxins [e.g., 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)], polychlorinated dibenzofurans, 
and  persistent  pesticides,  such  as  dichlorodiphenyltrichloroethane  (DDT)  [10].  PCBs  were 
manufactured in the U.S. from 1929 through 1976 for a variety of industrial purposes as determined by 
the  compounds’  low  electrical  and  thermal  conductivity.  PCBs  were  used  in  dielectric  fluids  in 
capacitors  and  transformers;  they  have  also  been  used  in  plasticizers,  adhesives,  paints,  pesticide 
extenders, hydraulic fluids, flame retardants and dyes for carbonless copy paper [11,12]. Inadequate 
manufacturing control, flaws in waste management, old electrical equipment disposal, and garbage 
incineration  are  among  sources  of  environmental  contamination  with  POP  [13].  POP  are  known 
carcinogens and endocrine disruptors; they have neurotoxicity and immunotoxicity properties and can 
cause birth defects [12,14].  
Recent  cell  studies  reported  that  POP  can  interfere  with  insulin  signaling  pathway  and  induce 
insulin resistance [15,16]. Results from a limited number of studies are indicative of serum levels of 
POP being associated with MetS prevalence [17,18]. This prompted us to investigate MetS-associated 
hospitalizations  in  relation  to  environmental  contamination  with  POP.  We  hypothesized  that  Int. J. Environ. Res. Public Health 2011, 8                 
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residency in areas containing environmental sources of POP will be associated with an increase in 
MetS-associated hospitalization rates.  
2. Methods 
2.1. Study Population 
We conducted a population-based semi-ecological study of MetS-related hospitalizations in relation 
to presumed environmental exposure to POP, based on zip codes of residence. Semi-ecological designs 
are used widely in environmental exposure studies. They utilize exposure status measurement on a 
group level combined with confounder measurement (such as patients’ gender, age, and race) on an 
individual level [19,20]. Patients residing in zip codes containing or abutting POP-contaminated waste 
sites were considered environmentally exposed to POP. Hospitalization data were obtained from the 
New York State (NYS) Statewide Planning and Research Cooperative System (SPARCS) database 
maintained by the NYS Department of Health. SPARCS is an administrative database; it contains 
formalized and coded data derived from hospital charts. All state-regulated hospitals in NYS report 
each patient’s medical (the principal diagnosis and up to 14 secondary diagnoses) and demographical 
(such as patient’s age, gender, and race)  information to the NYS Department of Health. The few 
hospitals  that  are  exempt  from  this  systematic  reporting  are  federal  hospitals,  including  the  ones 
operated by the U.S. Department of Veterans Affairs.  
Both the principal and secondary diagnoses are coded according to the International Classification 
of Diseases, the Ninth Revision, Clinical Modification (ICD-9-CM). We used data for a three-year 
period  of  2002–2004  for  NYS  except  for  New  York  City.  New  York  City  maintains  its  own 
hospitalization database and its population structure is different from the rest of the NYS. MetS-related 
hospitalizations were identified as hospitalizations containing the ICD-9-CM diagnosis code 277.7 as 
either the principal or a secondary diagnosis in the hospital discharge record. This ICD-9-CM code for 
the MetS was approved by the National Center for Health Statistics in 2001 [21].  
Patients’ environmental exposure status was designated as ―POP‖ or ―non-POP‖ based on their 
residence in zip codes containing or abutting hazardous waste sites known to contain dioxins/furan, 
PCBs or persistent pesticides; details of these classifications were described elsewhere [22]. Zip codes’ 
―POP‖ status was determined based on the data on 818 hazardous waste sites identified by the New 
York  State  Department  of  Environmental  Conservation  as  ―State  Superfund‖  sites;  additionally,  
the  zip  codes  abutting  POP-contaminated  portions  of  the  Hudson  River  and  the  six  Areas  of  
Concern—polluted bodies of water as defined by the U.S.-Canadian Joint Commission—were also 
classified as ―POP‖ zip codes [23]. Lower socio-economic status is often associated with a decreased 
access to health care, as many of these patients cannot afford to seek medical help and hospitalization. 
Consequently inclusion of persons of lower socio-economic status often distorts results due to the 
misbalanced  underrepresentation  of  the  disadvantaged  population  among  hospitalized  patients, 
especially in cases of a non-acute or immediately life-threatening illness. Restriction of the population 
studied by income is a valid and commonly used method to control for socio-economic status [24,25]. 
Thus in this study we restricted our analysis to those zip codes only in the three upper quartiles of 
median household income. After the income restriction was applied, there were 117 ―POP‖ zip codes Int. J. Environ. Res. Public Health 2011, 8                 
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in the study and 584 ―non-POP‖ zip codes. Of the ―non-POP‖ zip codes, 133 zip codes contained or 
abutted sources of environmental contaminants other than POP, and 451 zip codes contained or abutted 
no known hazardous waste sites.  
Data on race, gender, age, and income by zip code were obtained from Claritas, Inc., derived from 
the  US  Census.  Because  patients  of  the  two  largest  racial  groups—Caucasians  and  African 
Americans—comprised more than 98% of the residential NYS population exclusive of New York City 
and accounted for more than 98% of the MetS-associated hospitalizations, other racial groups were not 
included for the purpose of minimizing extra variability and preserving the parsimony of the model.  
After the above restrictions were applied, there were a total of 408 MetS-associated hospitalizations 
among  25-years  and  older  adults  during  18,113,583  person-years,  over  a  three-year  period  of  
2002–2004.  
2.2. Statistical Analysis 
The primary outcome variable was the MetS-associated hospitalization rate. Hospitalization rates 
(per 100,000 person-years, over a three-year period) were calculated as a number of MetS-associated 
hospitalizations divided by the population residing in a given zip code multiplied by 100,000.  
Relative risks (RR) of MetS-associated hospitalization in relation to POP exposure status were 
calculated as hospitalization rate ratios. The multivariable Poisson regression was utilized to obtain RR 
of MetS-associated hospitalization, with respective 95% confidence intervals (95% CI). Multivariable 
adjusted  analysis  was  used  to  control  for  confounding  by  age,  race,  and  gender  by  including  the 
respective variables into the multivariable model.  
All  statistical  analyses  were  performed  with  SAS  software,  version  9.2  (SAS  Institute  Inc.,  
Cary, NC). The PROC GENMOD procedure was used to conduct the multivariable Poisson regression. 
To adjust for overdispersion, a scaling factor was used; the scaled Pearson chi-square was equal 1.  
A conventional p < 0.05 value (type I error alpha = 0.05) was used for all analyses. 
3. Results 
3.1. Patient Characteristics 
The mean ±  SD age of the patients was 58.9 ±  14.4 years. Almost 55% of hospitalized patients were 
women  (224  cases)  and  about  45%  were  men  (184  cases).  Of  the  total  of  408  MetS-associated 
hospitalizations over a three-year period, 16 (4%) were African American and 392 (96%) Caucasian, 
which  reflects  the  fact  that  African  Americans  constitute  6%  and  Caucasians  94%  of  the  study 
population. Table 1 shows the distribution of the demographic characteristics of the study population 
in relation to presumed environmental exposure status. While of the total study population, 24.4% 
resided in  zip  codes containing  or abutting environmental sources of POP,  race-stratified analysis 
indicated  that  this  proportion  was  statistically significantly  higher  among  African  Americans  than 
Caucasians (25.9% and 24.3% residing in POP zip codes, respectively; p < 0.01).  
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Table 1. Demographic characteristics of the study population by residential proximity to 
environmental sources of POP (2002–2004), person-years (%).  
Population groups  POP  Non-POP  Total 
Race:       
African Americans  279,804 (25.9)  802,119 (74.1)  1,081,923 (100.0) 
Caucasians  4,146,579 (24.3)  12,885,081 (75.7)  17,031,660 (100.0) 
Age:       
25–34 years  977,889 (25.1)  2,913,609 (74.9)  3,891,498 (100.0) 
35–44 years  1,046,424 (24.3)  3,262,539 (75.7)  4,308,963 (100.0) 
45–54 years  809,217 (22.9)  2,717,067 (77.1)  3,526,284 (100.0) 
55–64 years  607,584 (23.7)  1,954,566 (76.3)  2,562,150 (100.0) 
65–74 years  533,748 (25.5)  1,557,114 (74.5)  2,090,862 (100.0) 
75+ years  451,521 (26.0)  1,282,305 (74.0)  1,733,826 (100.0) 
Gender:       
males  2,077,314 (24.3)  6,470,253 (75.7)  8,547,567 (100.0) 
females  2,349,069 (24.6)  7,216,947 (75.4)  9,566,016 (100.0) 
Total study population  4,426,383 (24.4)  13,687,200 (75.6)  18,113,583 (100.0) 
 
Both  unadjusted  (not  controlled  for  confounding)  and  adjusted  (controlled  for  confo unding) 
analyses were conducted. Unadjusted analyses provided preliminary information on the distribution of 
MetS-associated hospitalizations across different race, age, and gender groups. Adjusted analyses were 
conducted afterwards for the purpose of investigating whether an association between residence in a 
POP zip code and MetS-associated hospitalizations exists.  
3.2. Unadjusted Analysis 
While unadjusted MetS-associated hospitalization rates were lower in African Americans than in 
Caucasians, the difference was not statistically significant (unadjusted rates per 100,000 person-years: 
1.48 and 2.30, respectively; unadjusted RR = 0.643, 95% CI: 0.390–1.059; p = 0.083) (Table 2). 
Unadjusted  analysis  of  gender  differences  in  MetS-associated  hospitalizations  (Table  2)  indicated  
that  males  have  a  slightly  lower  unadjusted  rate  (2.15  per  100,000  person-years)  than  females  
(2.34 per 100,000 person-years), with the difference not being statistically significant (p = 0.398).  
Unadjusted analysis of MetS-associated hospitalizations in relation to age indicated a statistically 
significant increase of hospitalization rates with age (Table 2). Different patterns in hospitalization 
rates were observed for ages up to 44 years and 45 years and older. MetS-associated hospitalization 
rates  in  the  former  groups  (0.31  to  0.79  per  100,000  person-years)  were  lower  than  the  average 
hospitalization rate (2.18 per 100,000 person-years), while in the latter age groups they exceeded the 
average and ranged from 2.84 to 4.21 per 100,000 person years (Table 2). Int. J. Environ. Res. Public Health 2011, 8                 
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Table 2. Unadjusted hospital admission rates (per 100,000 person-years) and unadjusted 
relative risks of MetS-associated hospital admission, by race, gender, and age. 
Population 
characteristics 
Unadjusted MetS-associated 
hospital admission rates (95% 
CI), per 100,000 person-years  
Unadjusted RR 
(95% CI) 
p value 
Race:       
Caucasians (reference)  2.30 (2.07–2.53)  1.0   
African Americans  1.48 (0.75–2.20)  0.643 (0.390–1.059)  0.083 
Gender:       
females (reference)   2.34 (2.03–2.65)  1.0   
males  2.15 (1.84–2.46)  0.919 (0.755–1.116)  0.398 
Age:       
25–34 years (reference)   0.31 (0.13–0.48)  1.0  <0.01* 
35–44 years  0.79 (0.52–1.05)  2.559 (1.325–4.942)   
45–54 years  2.84 (2.28–3.39)  9.197 (5.053–16.737)   
55–64 years  4.06 (3.28–4.84)  13.164 (7.242–23.927)   
65–74 years  4.07 (3.20–4.93)  13.184 (7.204–24.129)   
75+ years  4.21 (3.24–5.18)  13.654 (7.415–25.143)   
Income (quartiles of median household income): 
quartile 1 (reference)  4.61 (3.76–5.47)  1.0  <0.01* 
quartile 2  2.91 (2.34–3.49)  0.632 (0.480–0.827)   
quartile 3  2.90 (2.47–3.33)  0.629 (0.499–0.804)   
quartile 4  1.54 (1.28–1.80)  0.333 (0.259–0.430)   
* p value for trend, Wald statistic. 
 
Stratified unadjusted analyses, comparing MetS-associated hospitalization rates in the populations 
of  POP  and  non-POP  zip  codes,  were  conducted  separately  for  race,  gender,  and  age  categories   
(Table  3).  Both  African  Americans  and  Caucasians  residing  in  POP  zip  codes  had  higher 
hospitalization rates; however, in African Americans the effect of the presumed exposure status was 
not  statistically  significant  (unadjusted  RR  =  1.303,  95%  CI:  0.268 –3.360,  p  =  0.623),  while  in 
Caucasians it was (unadjusted RR = 1.421, 95% CI: 1.137–1.746, p < 0.001). The presumed POP 
exposure status was also associated with an increase in MetS-related hospitalizations in both men and 
women; it was statistically significant for women (unadjusted RR = 1.609, 95% CI: 1.204–2.099,  
p < 0.01), but not for men (unadjusted RR = 1.194, 95% CI: 0.840–1.618, p = 0.280). Analysis of 
hospitalization rates by age indicated that in all but the youngest (ages 25–34 years) of the six age 
categories,  the  presumed  exposure  to  POP  was  associated  with  an  increase  in  MetS-related 
hospitalizations, although not statistically significant.  
The two different patterns of MetS-associated hospitalizations by age described above for the entire 
study population were also found in a stratified analysis. Hospitalization rates in the two youngest 
categories were below the respective POP and non-POP average hospitalization rates (POP average: 
2.89 per 100,000 person-years; non-POP average: 2.05 per 100,000 person-years), while for the ages 
of 45 years and older they were above average (Figure 1) for residents of both POP and non-POP  
zip codes. Int. J. Environ. Res. Public Health 2011, 8                 
 
768 
Table 3. Unadjusted MetS-associated hospital admission rates (per 100,000 person-years) 
and unadjusted relative risks of hospital admission in relation to residential proximity to 
environmental sources of POP. 
Population characteristics  Unadjusted MetS-associated 
hospital admission rates (95% CI), 
per 100,000 person-years 
Unadjusted RR  
(95% CI) 
p value 
Race:       
African Americans       
non-POP (reference)  1.37 (0.56–2.18)  1.0   
POP  1.79 (0.22–3.35)  1.303 (0.268–3.360)  0.623 
Caucasians       
non-POP (reference)  2.09 (1.84–2.34)  1.0   
POP  2.97 (2.44–3.49)  1.421 (1.137–1.746)  <0.001 
Gender:       
females       
non-POP (reference)  2.04 (1.71–2.37)  1.0   
POP  3.28 (2.55–4.10)  1.609 (1.204–2.099)  <0.01 
males       
non-POP (reference)  2.06 (1.71–2.40)  1.0   
POP  2.46 (1.78–3.13)  1.194 (0.840–1.618)  0.280 
Age:       
25–34 years       
non-POP (reference)  0.31 (0.11–0.51)  1.0   
POP  0.31 (0.06–0.65)  0.993 (0.015–2.920)  0.992 
35–44 years       
non-POP (reference)  0.74 (0.44–1.03)  1.0   
POP  0.96 (0.36–1.55)  1.299 (0.512–2.523)  0.486 
45–54 years       
non-POP (reference)  2.50 (1.91–3.10)  1.0   
POP  3.95 (2.58–5.32)  1.580 (0.995–2.347)  0.186 
55–64 years       
non-POP (reference)  3.58 (2.74–4.42)  1.0   
POP  5.60 (3.71–7.48)  1.563 (0.998–2.302)  0.186 
65–74 years       
non-POP (reference)  3.85 (2.88–4.83)  1.0   
POP  4.68 (2.85–6.52)  1.216 (0.717–1.873)  0.411 
75+ years       
non-POP (reference)  3.82 (2.75–4.89)  1.0   
POP  5.32 (3.19–7.44)  1.391 (0.806–2.200)  0.183 
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Figure 1. Unadjusted MetS-associated hospitalization rates (per 100,000 person-years) in 
relation to POP status, by age. 
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3.3. Multivariable Adjusted Analysis 
While unadjusted analysis provides useful information on the distribution of hospitalization rates 
across  different  population  groups,  it  cannot  be  used  for  making  conclusions  on  whether 
hospitalization  rates  are  associated  with  exposure,  because  the  results  are  not  controlled  for 
confounding. To investigate whether residence in POP zip codes is associated with an increase in 
MetS-associated  hospitalization  rates  after  controlling  (adjusting)  for  race,  gender  and  age,  we 
conducted a multivariable adjusted analysis, using a multivariable Poisson regression model.  
Results of the multivariable Poisson regression analysis are presented in Table 4. After adjusting for 
race, gender, and age, residence in a POP zip code was associated with a statistically significant 39.2% 
increase in MetS-related hospitalization rates (adjusted RR = 1.392, 95% CI: 1.032–1.879, p = 0.030). 
After controlling for the POP exposure status, gender, and age, race was no longer associated with 
increased hospitalization rates (p = 0.609). After controlling for POP exposure status, race, and age, 
gender  also  was  not  associated  with  MetS-related  hospitalization  rates.  Age,  however,  remained 
associated  with  an  increase  in  hospitalization  rates  in  the  multivariable  adjusted  analysis  (p  for  
trend < 0.001).  Int. J. Environ. Res. Public Health 2011, 8                 
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Table 4. Multivariable adjusted relative risks of MetS-associated hospitalization in relation 
to residential proximity to environmental sources of POP and demographic characteristics.  
Parameter  β coefficient 
Standard 
error 
Multivariable adjusted  
RR (95% CI) 
p value 
POP (compared to non-POP)
1  0.331  0.153  1.392 (1.032–1.879)  0.030 
African Americans  
(compared to Caucasians)
2 
–0.188  0.366  0.829 (0.404–1.700)  0.609 
Males (compared to females)
3  0.003  0.144  1.003 (0.757–1.328)  0.984 
Age (compared to 25–34 years)
4        <0.001* 
35–44 years  0.928  0.481  2.530 (0.985–6.497)   
45–54 years  2.181  0.438  8.857 (3.754–20.897)   
55–64 years  2.523  0.437  12.461 (5.290–29.353)   
65–74 years  2.531  0.442  12.560 (5.278–29.886)   
75+ years   2.568  0.447  13.042 (5.427–31.350)    
1Adjusted  for gender,  race, and age; 
2Adjusted  for exposure  status,  gender, and  age; 
3Adjusted  for 
exposure status, race, and age; 
4Adjusted for exposure status, gender, and race; *p value for trend,  
Wald statistic. 
4. Discussion 
In this study we found that residence in zip codes containing or abutting environmental sources of 
POP  is  associated  with  a  statistically  significant  39.2%  increase  in  MetS-related  hospitalizations 
compared to residents of non-POP zip codes. To our knowledge, this is the first study investigating the 
association between the presumed environmental exposure to POP based on residence near to a POP 
hazardous waste site and MetS employing hospitalization rate as the outcome of interest.  
We  chose  to  focus  on  this  outcome  for  two  reasons.  Firstly,  while  an  increased  MetS-related 
hospitalization  rate  does  not  prove  a  causal  effect  of  POP,  it  is  reasonable  to  expect  that  the 
hypothesized association between POP and MetS does exist. Our previous studies using hospitalization 
in relation to residence near to POP sites have reported elevated risk of diabetes [26], hypertension 
[22], and cardiovascular [27] and cerebrovascular disease [28,29]. In addition, studies in which PCBs 
and pesticides were measured in serum have demonstrated statistically significant relations between 
exposure  and  diabetes  [30,31],  obesity  [32],  hyperlipidemia  [33]  and  hypertension  [34],  each  one 
component of MetS. Secondly, the concept of the environmental burden of disease is important from 
the  public  health  and  health  care  perspectives  [35,36],  and  hospital  utilization  is  an  essential 
component of this concept.  
Our results are consistent with findings from other population-based studies of exposure to POP and 
MetS,  or  MetS  components,  that  were  conduced  using  different  approaches.  Chang  et  al.  (2011) 
investigated  insulin  resistance  in  non-diabetic  adults  residing  near  a  deserted  pentachlorophenol 
factory  that  generated  polychlorinated  dibenzo-p-dioxins  and  furans  as  byproducts.  They  found  a 
statistically  significant  positive  association  between  serum  dioxin  levels  and  homeostasis  model 
assessment—insulin  resistance  (HOMA-IR;  higher  values  indicative  of  insulin  resistance),  fasting 
glucose, systolic and diastolic blood pressure, waist circumference, and HDL cholesterol level [37]. Int. J. Environ. Res. Public Health 2011, 8                 
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Cranmer et al. (2000) studied association between environmental residential exposure to TCDD and 
insulin  levels  in  69  subjects  with  normal  glucose  tolerance  test  who  lived  within  25  miles  of  a 
Superfund  site  in  Arkansas  [38].  The  source  of  TCDD  contamination  was  a  plant  where  the  
TCDD-containing component of Agent Orange was manufactured and from which TCDD spread into 
the environment due to lack of adequate production control and waste disposal. High blood TCDD 
levels were found to be associated with higher levels of both fasting insulin and insulin at 30, 60, and 
120 minutes after oral glucose load. 
Using the National Health and Nutrition Examination Survey data, Lee et al. (2007) investigated 
cross-sectional associations between POP and MetS among 721 adults, of whom 175 individuals had 
MetS  [17].  They  found  that  serum  concentrations  of  organochlorine  pesticides  and  dioxin-like 
polychlorinated biphenyls (PCBs) were positively associated with the prevalence of the MetS. The 
dose-response  relationship  between  non-dioxin-like  PCBs  and  the  MetS  was  inverted-U-shaped,  
with the association being the strongest for the two middle quartiles of serum POP levels. Serum  
levels  of  other  POP  investigated  in  that  study  (polychlorinated  dibenzofurans  and  polychlorinated  
dibenzo-p-dioxins) were found to be associated with only one of the MetS components—HTN.  
In a study of 160 MetS patients among 1,374 Japanese residents non-occupationally exposed to 
POP,  Uemura  et  al.  (2009)  found  that  body  burden  levels  of  polychlorinated  dibenzofurans, 
polychlorinated  dibenzo-p-dioxins,  and  dioxin-like  PCBs  were  statistically  significantly  associated 
with the prevalence of the MetS [18].  
While the exact pathogenic mechanisms involved in the association between POP and the MetS 
have  not  been  established  with  certainty,  results  from  a  number  of  studies  indicate  that  insulin 
resistance  and  changes  in  gene  regulation  caused  by  POP  play  the  major  role.  POP  can  increase 
secretion  of  tumor  necrosis  factor  alpha  (TNF-α),  which  plays  an  essential  role  in  development  
of  insulin  resistance.  The  insulin  resistance-inducing  effect  of  TNF-α  is  established  [39-41].  
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) has been shown to stimulate TNF-α and inhibit glucose 
transport in adipose cells (adipocytes) [15,42]. TCDD interferes with the insulin signaling pathway  
by  decreasing  the  expression  levels  of  insulin  receptors  and  glucose  transporter  GLUT-4  that  
results in inhibiting insulin-stimulated glucose uptake [16]. The underlying mechanism of the insulin  
resistance-inducing effect of TCDD  is  stimulation of  TNF-α  production [16]. TNF-α  substantially 
decreases GLUT-4 [43]. TNF-α activates nuclear factor kappa B (NF-κB)—an obligatory mediator of 
the  changes  in  gene  expression  induced  by  TNF-α,  including  GLUT-4.  This  pathway  leads  to 
development of insulin resistance [44].  
The role of the TNF-α  NF-κB  GLUT4 pathway in POP-induced glucose intolerance was also 
demonstrated in a study of United States Air Force veterans of the Vietnam War who were involved 
with spraying the Agent Orange herbicide that was contaminated with TCDD. Fujiyoshi et al. (2006) 
investigated the NF-κB:GLUT4 ratio in the exposed veterans, as compared to the veterans without 
history of exposure, and found that this ratio is significantly correlated with serum dioxin levels [45]. 
In another study of the exposed veterans, Michalek et al. (1999) found elevated levels of insulin in 
non-diabetic veterans [46]. High insulin levels would be expected in the MetS.  
Although investigating MetS-associated hospitalization in relation to demographic characteristics 
was not a goal of our study, these results may be worth a brief discussion. Prevalence of the MetS  
is  known  to  increase  with  age  [4,47].  Our  findings  are  consistent  with  this  knowledge,  in  that  Int. J. Environ. Res. Public Health 2011, 8                 
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MetS-associated hospitalization rates increased with age (p for trend < 0.001). While MetS prevalence 
is higher in men than in women and in Caucasians than in African Americans, gender and racial 
differences in the MetS components vary substantially [4,48]. While hypertriglyceridemia, HTN, and 
high fasting glucose are more prevalent in men, abdominal obesity and low HDL cholesterol are more 
prevalent in women [4]. Abdominal obesity, hypertriglyceridemia, low HDL cholesterol, and high 
fasting glucose are more prevalent in Caucasians, but HTN is more prevalent in African Americans [4]. 
In  our  study,  racial  and  gender  differences  in  MetS-associated  hospitalization  (higher  rates  in 
Caucasians than in African Americans and in men than in women) were not statistically significant. 
Probably,  racial  and  gender  differences  appearing  in  MetS  prevalence  became  smoothed  in  
MetS-associated  hospitalization  rates  because  diseases  and  conditions  that  do  not  constitute  an 
immediate threat to patient’s life or risk of permanent and severe disability if not treated promptly may 
be underrepresented in hospital settings.  
Our study is not free from limitations. Exposure status information was available only on a zip 
code-level (group level), which is a very crude measure of exposure. Group-level measurements are a 
common limitation intrinsic to ecological and semi-ecological studies. Therefore, the results of such 
studies  cannot  be  extrapolated  to  individual  level  because  of  ecological  fallacy  problem  [49,50].  
It  should  be  noted,  however,  that  ecological  design  remains  valuable  for  studies  investigating  
population-level processes and effects, such as an extent of public health impact of social processes 
and  outcomes  of  public  health  interventions  [49,51].  Only  data  on  hospital  discharges  from  
State-regulated hospitals were used, as data from Federal hospitals were not available. We also utilized 
only the ICD-9 code for MetS, not that for the components of the disease. This may have resulted in an 
underestimation of the true rate of the MetS. 
It can be reasonably argued that crude measurement of exposure might have produced a dilution 
effect, thus weakening the measure of association (underestimation of RR) due to non-differential 
misclassification.  That  means  that  if  exposure  status  was  measured  more  accurately,  the  true  RR 
obtained  in  such  a  study  would  have  been  even  higher,  indicating  stronger  association  between 
exposure and outcome. Since exposure and outcome status were estimated independently from each 
other, using independent sources of data, differential misclassification is unlikely in our study.  
5. Conclusions 
In conclusion, our findings contribute to the body of evidence supporting the hypothesis of POP 
constituting an environmental risk factor for the MetS. Further studies of POP exposure and the MetS 
with individual level measurements of exposure and outcome, including measures of insulin resistance, 
are warranted. Given the involuntary nature of environmental residential exposure to POP that may 
affect a substantial portion of population, it is imperative to develop and implement respective public 
health and environmental health policy interventions aimed at reducing and eliminating POP exposure.  
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